Search alternatives:
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1
-
2
-
3
-
4
-
5
(A) Digital designing of premolar to decrease 1 mm of root surface, (B) 3D printed tooth compared to artificial tooth of model.
Published 2025“…<p>(A) Digital designing of premolar to decrease 1 mm of root surface, (B) 3D printed tooth compared to artificial tooth of model.…”
-
6
-
7
-
8
Juvenile demyelination leads to a decrease in axonal complexity of PFC PV interneurons.
Published 2025“…<p><b>A.</b> Experimental design to induce juvenile demyelination in PV-tdTomato mice <b>B.…”
-
9
-
10
-
11
Quinoline-Based DNA Methyltransferase Inhibitors Featuring Basic Side Chains: Design, Synthesis, and Insight in Biochemical and Anticancer Cell Properties
Published 2025“…The quinoline DNMT inhibitors <b>4</b>–<b>21</b>, incorporating basic chains, were designed, synthesized, and evaluated for their ability to inhibit DNMT1 and DNMT3<i>A</i>/3L by directly measuring DNA methylation. …”
-
12
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
13
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
14
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
15
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
16
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
-
17
Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the Brain
Published 2025“…Pretreatment with S1PR5 potent modulators effectively impacted rodent brain uptake of [<sup>18</sup>F]<b>7a</b>. Cuprizone-fed mice had reduced [<sup>18</sup>F]<b>7a</b> brain uptake, reflecting the loss of oligodendrocytes and decreased S1PR5 expression. …”
-
18
Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the Brain
Published 2025“…Pretreatment with S1PR5 potent modulators effectively impacted rodent brain uptake of [<sup>18</sup>F]<b>7a</b>. Cuprizone-fed mice had reduced [<sup>18</sup>F]<b>7a</b> brain uptake, reflecting the loss of oligodendrocytes and decreased S1PR5 expression. …”
-
19
Design and Synthesis of Novel PET Radiotracers for Imaging Sphingosine-1-Phosphate Receptor 5 (S1PR5) in the Brain
Published 2025“…Pretreatment with S1PR5 potent modulators effectively impacted rodent brain uptake of [<sup>18</sup>F]<b>7a</b>. Cuprizone-fed mice had reduced [<sup>18</sup>F]<b>7a</b> brain uptake, reflecting the loss of oligodendrocytes and decreased S1PR5 expression. …”
-
20